EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Unraveling the molecular determinants of a rare human mitochondrial disorder caused by the P144L mutation of FDX2

Deborah Grifagni, Davide Doni, Bianca Susini, Bruno M Fonseca, Ricardo O Louro iD, Paola Costantini iD, Simone Ciofi-Baffoni iD

Protein Science · 2024

DOI: 10.1002/pro.5197 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Protein Science, 2024. Verfasst von Deborah Grifagni und 6 weiteren Autor:innen. Beteiligte Einrichtung: Magnetic Resonance Center CERM, University of Florence, Florence, Italy. Hauptthemen laut MEDLINE: Ferredoxins. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 58 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Fondazione Telethon and Fondazione CARIPLO, COST Action FeSImmChemNet, CA21115, European Union-NextGenerationEU-National Recovery and Resilience Plan, Mission 4 Component 2-Investment 1.5-THE-Tuscany Health Ecosystem-ECS00000017-CUP B83C22….

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Episodic mitochondrial myopathy with or without optic atrophy and reversible leukoencephalopathy (MEOAL) is a rare, orphan autosomal recessive disorder caused by mutations in ferredoxin‐2 (FDX2), which is a [2Fe‐2S] cluster‐binding protein participating in the formation of iron–sulfur clusters in mitochondria. In this biosynthetic pathway, FDX2 works as electron donor to promote the assembly of both [2Fe‐2S] and [4Fe‐4S] clusters. A recently identified missense mutation of MEOAL is the homozygous mutation c.431C>T (p.P144L) described in six patients from two unrelated families. This mutation alters a highly conserved proline residue located in a loop of FDX2 that is distant from the [2Fe‐2S] cluster. How this Pro to Leu substitution damages iron–sulfur cluster biosynthesis is unknown. In this work, we have first compared the structural, dynamic, cluster binding and redox properties of WT and P144L [2Fe‐2S] FDX2 to have clues on how the pathogenic P144L mutation can perturb the FDX2 function. Then, we have investigated the interaction of both WT and P144L [2Fe‐2S] FDX2 with its physiological electron donor, ferredoxin reductase FDXR, comparing their electron transfer efficiency and protein–protein recognition patterns. Overall, the data indicate that the pathogenic P144L mutation negatively affects the FDXR‐dependent electron transfer pathway from NADPH to FDX2, thereby reducing the capacity of FDX2 in assembling both [2Fe‐2S] and [4Fe‐4S] clusters. Our study also provided solid molecular evidences on the functional role of the C‐terminal tail of FDX2 in the electron transfer between FDX2 and FDXR.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

FerredoxinsHumansIron-Sulfur ProteinsMitochondrial DiseasesModels, MolecularMutation, MissenseOxidation-Reduction

Stichwörter der Autor:innen

FDX2ISC machineryMEOALNMRP144Liron–sulfur proteinrare disease

Substanzen

FerredoxinsIron-Sulfur ProteinsFDX2 protein, human

Autor:innen und Institutionen

  • Magnetic Resonance Center CERM, University of Florence, Florence, Italy.
  • Department of Chemistry, University of Florence, Florence, Italy.
  • Department of Biology, University of Padova, Padova, Italy.
  • Instituto de Tecnologia Química e Biológica António Xavier (ITQB-NOVA), Universidade Nova de Lisboa, Oeiras, Portugal.

ORCID-Profile: Ricardo O Louro, Paola Costantini, Simone Ciofi-Baffoni

Förderung

  • Fondazione Telethon and Fondazione CARIPLO
  • COST Action FeSImmChemNet, CA21115
  • European Union-NextGenerationEU-National Recovery and Resilience Plan, Mission 4 Component 2-Investment 1.5-THE-Tuscany Health Ecosystem-ECS00000017-CUP B83C22…
  • Italian Ministry of University and Research (MUR), Department of Excellence 2023-2027 (DICUS 2.0)
  • Project MOSTMICRO-ITQB
  • LS4FUTURE Associated Laboratory
  • Ministero dell'Università e della Ricerca

Zitieren

APA

Grifagni, D., Doni, D., Susini, B., Fonseca, B. M., Louro, R. O., Costantini, P., & Ciofi-Baffoni, S. (2024). Unraveling the molecular determinants of a rare human mitochondrial disorder caused by the P144L mutation of FDX2. Protein Science. https://doi.org/10.1002/pro.5197

Vancouver

Grifagni D, Doni D, Susini B, Fonseca BM, Louro RO, Costantini P, et al. Unraveling the molecular determinants of a rare human mitochondrial disorder caused by the P144L mutation of FDX2. Protein Science. 2024. doi:10.1002/pro.5197

BibTeX
@article{Grifagni2024,
  author = {Grifagni, Deborah and Doni, Davide and Susini, Bianca and Fonseca, Bruno M and Louro, Ricardo O and Costantini, Paola and Ciofi-Baffoni, Simone},
  title = {Unraveling the molecular determinants of a rare human mitochondrial disorder caused by the P144L mutation of FDX2},
  journal = {Protein Science},
  year = {2024},
  doi = {10.1002/pro.5197}
}
Kostenlos starten →